07/19/2025                                                                            
                                    
                                                                            
                                            108 MILLION WOMEN. STILL NO FDA-APPROVED TESTOSTERONE. 
Your high-functioning sister breaks her hip. She’s one of six in ten women who will.
Now imagine there’s a drug, safe, cheap, decades-old, that could cut her risk of needing a cane by 50%.
That drug?
Testosterone.
Available to men since 1935.
Still unapproved for women in 2025.
Dr. Kelly Casperson just told the FDA what every woman deserves to hear:
“We can’t keep pretending the absence of treatment equals safety.”
Men have 12+ testosterone options. Women get NONE.
And the science? It’s NOT the issue.
Testosterone isn’t just about libido.
It powers:
- Brain health
- Bone strength
- Mitochondria
- Mood, energy, clarity
- Even memory!
So why are women still being dismissed?
💣 FDA rejected female doses TWICE.
Not because it didn’t work, but because of outdated safety fears.
Meanwhile, men’s versions were approved with just 6 months of data.
Trans men get 10x the dose.
Women are forced to pay cash.
This is NOT just a medical issue.
It’s a regulatory failure.
Dr. Casperson isn’t just speaking as a urologist.
She’s speaking for 108 million American women.
And she’s asking:
- Fast-track approval
- Use existing safety data
- Approve for hormone deficiency — NOT just low desire
- Remove DEA restrictions on low-dose female testosterone
🧠 Dementia.
🦴 Bone loss.
💊 Overmedication with antidepressants.
🎯 All while a proven hormone sits behind red tape.
This isn’t about age.
It’s about access.
And it's time.
👇 Should testosterone be FDA-approved for women? Drop your thoughts. Repost this. Let’s make it impossible to ignore.
See the 5-minute speech here by Dr. Casperson at the FDA Women’s Health Roundtable: Hormone Replacement Therapy (HRT) and Women’s Health:                                         
                                    
                                                                        
                                        At the recent  hearing on menopause and hormone therapy, Dr. Kelly Casperson addressed a critical gap in care: the absence of FDA-approved testostero...